MICROCURES INC
Santa Cruz, CA · Medtech · Private
Nanoparticle-encapsulated FL2-siRNA therapeutic for topical corneal wound healing
microcures.com →- Grants
- $11M
- 20 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 21
- 0 granted · 21 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a Topical siRNA Therapy to Promote Burn Wound Healing via Depletion of the Novel Microtubule Regulatory, Fidgetin-Like-2 | $224,913 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Topical siRNA Therapy to Promote Burn Wound Healing via Depletion of the Novel Microtubule Regulatory Fidgetin Like | $224,913 | |
| Federal grant | Department of Health and Human Services · Phase I · A Novel Therapeutic that Harnesses Microtubules to Promote Cavernous Nerve Regeneration after Radical Prostatectomy | $234,898 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · A Novel Therapeutic that Harnesses Microtubules to Promote Cavernous Nerve Regeneration after Radical Prostatectomy | $234,898 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · A Novel Therapeutic that Harnesses MIcrotubules to Enhance Corneal Wound Healing Following an Alkaline Burn | $213,405 | |
| Federal grant | Department of Health and Human Services · Phase I · A Novel Therapeutic that Harnesses MIcrotubules to Enhance Corneal Wound Healing Following an Alkaline Burn | $224,612 | |
| Federal grant | Department of Health and Human Services · Phase I · A Novel Therapeutic that Harnesses MIcrotubules to Enhance Corneal Wound Healing Following an Alkaline Burn | $11,207 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Development of A Topical siRNA Therapy to Promote Burn Wound Healing via Depletion of the Novel Microtubule Regulatory, Fidgetin-Like-2 | $1,491,014 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Development of A Topical siRNA Therapy to Promote Burn Wound Healing via Depletion of the Novel Microtubule Regulatory, Fidgetin-Like-2 | $823,988 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of A Topical siRNA Therapy to Promote Burn Wound Healing via Depletion of the Novel Microtubule Regulatory, Fidgetin-Like-2 | $667,026 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Therapeutic that Harnesses Microtubules to Promote Cavernous Nerve Regeneration after Radical Prostatectomy | $941,635 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Therapeutic that Harnesses Microtubules to Promote Cavernous Nerve Regeneration after Radical Prostatectomy | $1,686,452 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Therapeutic that Harnesses Microtubules to Promote Cavernous Nerve Regeneration after Radical Prostatectomy | $744,817 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Therapeutic to Promote Corneal Repair | $380,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A Novel Therapeutic to Promote Corneal Repair | $380,000 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Therapeutic to Promote Corneal Repair | $699,975 | |
| Federal grant | Department of Health and Human Services · Phase I · Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2. | $458,154 | |
| Federal grant | Department of Health and Human Services · Phase II · A Novel Therapeutic to Promote Corneal Repair | $699,917 | |
| Federal grant | Department of Health and Human Services · Phase I · Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2: Supplement for Imaging System | $44,744 | |
| Federal grant | Department of Health and Human Services · Phase I · Promoting tissue repair and functional recovery after spinal cord injury by targeting the microtubule regulatory protein Fidgetin-like 2. | $235,898 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2204 | NanoSoft, LLC | — | — |
| 2205 | POLARITYTE MD, INC. | — | — |
| 2206 | CICADEA BIOTECH, LLC | — | — |
| 2207 | MICROCURES INC | — | — |
| 2208 | BAY GENOMICS, LLC | — | — |
| 2209 | COGNIFISENSE, INC. | — | — |
| 2210 | VECTOR SURGICAL, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Fidgetin-like 2 As A Target To Enhance Wound Healingapplication
- Method For Enhancing Recovery Of Cosmetic Laser-treated Skinapplication
- Fidgetin-like 2 As A Target To Enhance Skin Graft Healingapplication
- Fidgetin-like 2 Sirna-enhanced Poloxamer-based Hydrogel For Wound Healingapplication
- Methods And Agents For Enhancing T Cell Therapiesapplication
- Method For Enhancing Recovery Of Cosmetic Laser-treated Skinapplication
- Method For Restoring Hair Follicles And Hair Growthapplication
- Fidgetin-like 2 As A Target To Enhance Wound Healingapplication
- Fidgetin-like 2 As A Target To Enhance Skin Graft Healingapplication
- Methods And Agents For Enhancing T Cell Therapiesapplication
- Fidgetin-like 2 Sirna-enhanced Poloxamer-based Hydrogel For Wound Healingapplication
- Method For Restoring Hair Follicles And Hair Growthapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.